ChiCTR2600120160 版本V1.0 版本创建时间2026/03/10 11:56:25 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600120160 

最近更新日期:

Date of Last Refreshed on:

2026-03-10 11:56:14 

注册时间:

Date of Registration:

2026-03-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

缺血性脑卒中恢复期患者动态症状群识别与时序首发症状挖掘研究

Public title:

Identification of dynamic symptom clusters and mining of the initial symptom in temporal sequence in patients during the recovery phase of ischemic stroke

注册题目简写:

English Acronym:

研究课题的正式科学名称:

缺血性脑卒中恢复期患者动态症状群识别与时序首发症状挖掘研究

Scientific title:

Identification of dynamic symptom clusters and mining of the initial symptom in temporal sequence in patients during the recovery phase of ischemic stroke

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

黄延锦 

研究负责人:

陈思妤 

Applicant:

Yanjin Huang 

Study leader:

Siyu Chen 

申请注册联系人电话:

Applicant telephone:

+86 157 7311 9440

研究负责人电话:

Study leader's
telephone:

+86 188 8620 4830

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2019000050@usc.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

18886204830@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国湖南省衡阳市蒸湘区红湘街道常胜西路28号

研究负责人通讯地址:

中国湖南省衡阳市蒸湘区红湘街道常胜西路28号

Applicant address:

No. 28, Changsheng West Road, Hongxiang Subdistrict, Zhengxiang District, Hengyang, Hunan, China

Study leader's address:

No. 28, Changsheng West Road, Hongxiang Subdistrict, Zhengxiang District, Hengyang, Hunan, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南华大学

Applicant's institution:

University of South China

研究负责人所在单位:

南华大学

Affiliation of the Leader:

University of South China

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

医伦审2025第0127号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南华大学医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of University of South China

伦理委员会批准日期:

Date of approved by ethic committee:

2025-11-26 00:00:00

伦理委员会联系人:

练高建

Contact Name of the ethic committee:

Gaojian Lian

伦理委员会联系地址:

中国湖南省衡阳市蒸湘区红湘街道常胜西路28号

Contact Address of the ethic committee:

No. 28, Changsheng West Road, Hongxiang Subdistrict, Zhengxiang District, Hengyang, Hunan, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 734 857 8139

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南华大学

Primary sponsor:

University Of South China

研究实施负责(组长)单位地址:

中国湖南省衡阳市蒸湘区红湘街道常胜西路28号

Primary sponsor's address:

No. 28, Changsheng West Road, Hongxiang Subdistrict, Zhengxiang District, Hengyang, Hunan, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖南

市(区县):

Country:

China

Province:

Hunan

City:

单位(医院):

南华大学

具体地址:

中国湖南省衡阳市蒸湘区红湘街道常胜西路28号

Institution
hospital:

University of South China

Address:

No. 28, Changsheng West Road, Hongxiang Subdistrict, Zhengxiang District, Hengyang, Hunan, China

经费或物资来源:

财政补助

Source(s) of funding:

Financial aid

研究疾病:

缺血性脑卒中  

Target disease:

Ischemic stroke

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

1.探究缺血性脑卒中恢复期患者症状发生现状及严重程度,分析患者症状严重程度随时间的变化,揭示恢复期症状的强度,为后续纵向研究奠定基础。2.通过纵向随访缺血性脑卒中恢复期患者,追踪患者在不同时间节点的症状群,采用广义估计方程比较症状群严重程度的变化规律;运用关联规则分析识别症状群的时序首发症状,为患者症状的综合管理与个性化护理提供证据支持。  

Objectives of Study:

1. To investigate the prevalence and severity of symptoms in patients during the recovery phase of ischaemic stroke, analyse the temporal progression of symptom severity, and elucidate the intensity of symptoms during recovery, thereby establishing a foundation for subsequent longitudinal studies. 2. Through longitudinal follow-up of patients in the recovery phase of ischaemic stroke, track symptom clusters at different time points. Employ generalised estimating equations to compare patterns of change in symptom cluster severity; utilise association rule analysis to identify the initial symptom in temporal sequence of symptom clusters, thereby providing evidence-based support for comprehensive symptom management and personalised care.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄≥18岁;2.首次发病;3.病情稳定,病程在2周~6个月(处于恢复期);4.无理解和阅读障碍;5.自愿参加本研究者;

Inclusion criteria

1. Age ≥ 18 years; 2. First episode of illness; 3. Stable condition, with illness duration between 2 weeks and 6 months (in the recovery phase); 4. No comprehension or reading difficulties; 5. Volunteers participating in this study;

排除标准:

1.伴有严重后遗症的缺血性脑卒中患者;2.既往有药物依耐、焦虑、抑郁、精神疾病病史;3.伴有严重脏器功能不全、恶病质、疾病终末期患者。

Exclusion criteria:

1. Patients with ischaemic stroke accompanied by severe sequelae; 2. Patients with a history of drug dependence, anxiety, depression, or psychiatric disorders; 3. Patients with severe organ dysfunction, cachexia, or terminal illness.

研究实施时间:

Study execute time:

From 2026-04-01 00:00:00 To 2026-11-15 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-04-15 00:00:00 To 2026-11-15 00:00:00

干预措施:

Interventions:

组别:

观察组(缺血性脑卒中患者)

样本量:

500

Group:

Observation group (patients with ischemic stroke)

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖南 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

衡阳市石鼓区人民街道社区卫生服务中心  

单位级别:

社区卫生服务中心  

Institution
hospital:

Shigu District People's Street Community Health Service Center

Level of the institution:

Community Health Service Center

测量指标:

Outcomes:

指标中文名:

身体功能

指标类型:

主要指标

Outcome:

physical function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛感

指标类型:

主要指标

Outcome:

pain sensation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

认知功能

指标类型:

主要指标

Outcome:

cognitive function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心理症状

指标类型:

主要指标

Outcome:

psychological symptom

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疲乏

指标类型:

主要指标

Outcome:

fatigue

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

自理能力

指标类型:

主要指标

Outcome:

self-care ability

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

步态

指标类型:

主要指标

Outcome:

gait

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集由研究调查人员查询的病例记录表采集,数据管理通过EpiData 3.1数据管理软件进行。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection was captured from case record forms queried by the study investigators, and data management was performed through EpiData3.1 management software.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-03-10 11:56:14